Physician profile
Richard Bene
NPI 1922059914
$1,692.01
in general payments reported to CMS, 2019-2025
12 companies · $417 in 2025
The $417 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $133 · 2021: $423 · 2022: $81.64 · 2023: $151 · 2024: $163 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $731.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $561.98 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Abbvie INC. | $263.60 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Sientra, INC. | $228.03 | 2020-2022 | |
| Motiva USA, LLC | $215.43 | 2025 | |
| Allergan, INC. | $209.22 | 2019-2021 | |
| Stryker Corporation | $72.28 | 2019 | |
| Tela Bio, INC. | $42.88 | 2024 | Ovitex 2s |
| Integra Lifesciences Corporation | $27.19 | 2019 | |
| Aroa Biosurgery Incorporated | $24.20 | 2025 | |
| Boston Scientific Corporation | $16.83 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $15.43 | 2024 | Exparel |
| Endo Pharmaceuticals INC. | $14.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Bene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.